Terms: = Thyroid cancer AND JUN, P05412, 3725, ENSG00000177606, AP1, c-Jun
138 results:
1. Prediction of potential mechanisms of rhubarb therapy for colorectal cancer based on network pharmacological analysis and molecular docking.
Yang F; Li X; Zhang Y; Ren Y; Zhang J; Xiao K
Medicine (Baltimore); 2024 Mar; 103(12):e37477. PubMed ID: 38518016
[TBL] [Abstract] [Full Text] [Related]
2. Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer.
Zhang Z; Zhou J; Guo R; Zhou Q; Wang L; Xiang X; Ge S; Cui Z
Medicine (Baltimore); 2023 Nov; 102(45):e34871. PubMed ID: 37960775
[TBL] [Abstract] [Full Text] [Related]
3. Systematic pharmacology-based strategy to explore the mechanism of Semen Strychni for treatment of papillary thyroid carcinoma.
Mao J; Tang L; Fang L; Tian C; Zhu Z; Li Y
Sci Rep; 2023 Oct; 13(1):18492. PubMed ID: 37898675
[TBL] [Abstract] [Full Text] [Related]
4. Network Pharmacological Analysis and Experimental Validation of the Effects of Silybin on Proliferation, Migration, and Immunotherapy of Papillary thyroid cancer.
Xie W; Li H; Lin Q; Ke N
Endocr Metab Immune Disord Drug Targets; 2024; 24(6):672-690. PubMed ID: 37855349
[TBL] [Abstract] [Full Text] [Related]
5. Targeting c-jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract] [Full Text] [Related]
6. Combination
Gunda V; Ghosh C; Hu J; Zhang L; Zhang YQ; Shen M; Kebebew E
Thyroid; 2023 Oct; 33(10):1201-1214. PubMed ID: 37675898
[No Abstract] [Full Text] [Related]
7. Differences in Transcriptomic Profiles of Brain and thyroid Tumors with NTRK Gene Rearrangement.
Kechin AA; Koryukov MA; Smertina MA; Borobova VS; Oscorbin IP; Ivanov AA; Bakharev SY; Boyarskikh UA; Kushlinskii NE; Filipenko ML
Bull Exp Biol Med; 2023 May; 175(1):78-85. PubMed ID: 37335445
[TBL] [Abstract] [Full Text] [Related]
8. Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells.
Zhang GQ; Xi C; Shen CT; Song HJ; Luo QY; Qiu ZL
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37260320
[TBL] [Abstract] [Full Text] [Related]
9. Association of soft drinks and 100% fruit juice consumption with risk of cancer: a systematic review and dose-response meta-analysis of prospective cohort studies.
Pan B; Lai H; Ma N; Li D; Deng X; Wang X; Zhang Q; Yang Q; Wang Q; Zhu H; Li M; Cao X; Tian J; Ge L; Yang K
Int J Behav Nutr Phys Act; 2023 May; 20(1):58. PubMed ID: 37189146
[TBL] [Abstract] [Full Text] [Related]
10. Investigation of the mechanism of Prunella vulgaris in treatment of papillary thyroid carcinoma based on network pharmacology integrated molecular docking and experimental verification.
Zhu X; Li Y; Wang X; Huang Y; Mao J
Medicine (Baltimore); 2023 Apr; 102(17):e33360. PubMed ID: 37115092
[TBL] [Abstract] [Full Text] [Related]
11. Assessment of demographic characteristics and histopathological pattern of thyroidectomies patients in a resource-limited setting: a retrospective cross-sectional study.
Ghabisha S; Ahmed F; Alyhari Q; Al-Wageeh S; Dajenah M; Altam A; Aljbri W; Al-Naggar A; Al-Shami E; Al-Mekhlafy Z; Badheeb M
Pan Afr Med J; 2022; 43():213. PubMed ID: 36974312
[TBL] [Abstract] [Full Text] [Related]
12. Icariin Induces Triple-Negative Breast cancer Cell Apoptosis and Suppresses Invasion by Inhibiting the JNK/c-jun Signaling Pathway.
Gao S; Zhang X; Liu J; Ji F; Zhang Z; Meng Q; Zhang Q; Han X; Wu H; Yin Y; Lv Y; Shi W
Drug Des Devel Ther; 2023; 17():821-836. PubMed ID: 36969705
[TBL] [Abstract] [Full Text] [Related]
13. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver cancer Stem Cells' Properties and Lenvatinib Resistance Through WNT/β-Catenin and Hippo Signaling Pathways.
Wang J; Yu H; Dong W; Zhang C; Hu M; Ma W; Jiang X; Li H; Yang P; Xiang D
Gastroenterology; 2023 May; 164(6):990-1005. PubMed ID: 36764493
[TBL] [Abstract] [Full Text] [Related]
14. To Explore the Inhibitory Mechanism of Quercetin in thyroid Papillary Carcinoma through Network Pharmacology and Experiments.
Sun Y; Xie W; Kang N; Yi J; Ruan X; Hu L; Zhao J; Zheng X; Wei S; Gao M
Dis Markers; 2022; 2022():9541080. PubMed ID: 36510497
[TBL] [Abstract] [Full Text] [Related]
15. Enhancer reprogramming promotes the activation of cancer-associated fibroblasts and breast cancer metastasis.
Li Q; Lv X; Han C; Kong Y; Dai Z; Huo D; Li T; Li D; Li W; Wang X; Zhao Q; Ming J; Yang W; Chen Y; Wu X
Theranostics; 2022; 12(17):7491-7508. PubMed ID: 36438487
[No Abstract] [Full Text] [Related]
16. Optimized thyroid transcription factor-1 core promoter-driven microRNA-7 expression effectively inhibits the growth of human non-small-cell lung cancer cells.
Chen S; Guan L; Zhao X; Yang J; Chen L; Guo M; Zhao J; Chen C; Zhou Y; Han Y; Xu L
J Zhejiang Univ Sci B; 2022 Nov; 23(11):915-930. PubMed ID: 36379611
[TBL] [Abstract] [Full Text] [Related]
17. Loss of thyroid gland circadian PER2 rhythmicity in aged mice and its potential association with thyroid cancer development.
Lee J; Sul HJ; Choi H; Oh DH; Shong M
Cell Death Dis; 2022 Oct; 13(10):898. PubMed ID: 36284088
[TBL] [Abstract] [Full Text] [Related]
18. Basolateral Sorting of the Sodium/Iodide Symporter Is Mediated by Adaptor Protein 1 Clathrin Adaptor Complexes.
Koumarianou P; Fernández-Méndez C; Fajardo-Delgado D; Mielu LM; Santisteban P; De la Vieja A
Thyroid; 2022 Oct; 32(10):1259-1270. PubMed ID: 35833460
[No Abstract] [Full Text] [Related]
19. A signature of circadian rhythm genes in driving anaplastic thyroid carcinoma malignant progression.
Xu T; Jin T; Lu X; Pan Z; Tan Z; Zheng C; Liu Y; Hu X; Ba L; Ren H; Chen J; Zhu C; Ge M; Huang P
Cell Signal; 2022 Jul; 95():110332. PubMed ID: 35430345
[TBL] [Abstract] [Full Text] [Related]
20. TSH-TSHR axis promotes tumor immune evasion.
Wu Z; Xi Z; Xiao Y; Zhao X; Li J; Feng N; Hu L; Zheng R; Zhang N; Wang S; Huang T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35101946
[TBL] [Abstract] [Full Text] [Related]
[Next]
